Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Dna X (SONM) Equity Ratio (2018 - 2025)

Historic Equity Ratio for Dna X (SONM) over the last 8 years, with Q3 2025 value amounting to 0.02.

  • Dna X's Equity Ratio fell 10558.09% to 0.02 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.02, marking a year-over-year decrease of 10558.09%. This contributed to the annual value of 0.14 for FY2024, which is 13593.79% down from last year.
  • Dna X's Equity Ratio amounted to 0.02 in Q3 2025, which was down 10558.09% from 0.04 recorded in Q2 2025.
  • In the past 5 years, Dna X's Equity Ratio registered a high of 0.48 during Q1 2021, and its lowest value of 0.14 during Q4 2024.
  • Its 5-year average for Equity Ratio is 0.28, with a median of 0.37 in 2022.
  • Per our database at Business Quant, Dna X's Equity Ratio surged by 11424.09% in 2023 and then crashed by 13593.79% in 2024.
  • Over the past 5 years, Dna X's Equity Ratio (Quarter) stood at 0.45 in 2021, then dropped by 17.65% to 0.37 in 2022, then grew by 6.9% to 0.4 in 2023, then tumbled by 135.94% to 0.14 in 2024, then soared by 87.85% to 0.02 in 2025.
  • Its Equity Ratio stands at 0.02 for Q3 2025, versus 0.04 for Q2 2025 and 0.03 for Q1 2025.